Finding Treatment Effects in Alzheimer Trials in the Face of Disease Progression Heterogeneity

R.J. Jutten*, S.A.M. Sikkes, W.M. van der Flier, P. Scheltens, P.J. Visser, B.M. Tijms, Alzheimer's Disease Neuroimaging Initiative

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Web of Science)
Original languageEnglish
Pages (from-to)E2673-E2684
Number of pages12
JournalNeurology
Volume96
Issue number22
DOIs
Publication statusPublished - 1 Jun 2021

Keywords

  • MILD COGNITIVE IMPAIRMENT
  • CLINICAL-TRIALS
  • PREDICT TIME
  • DEMENTIA
  • SOLANEZUMAB
  • SCALE

Cite this